Asterand, Lundbeck ink global framework research pact for human tissue samples & drug discovery services

Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, has entered into a Global Framework Research Agreement with Lundbeck A/S, a leading international pharmaceutical company focused on the development of medications for central nervous system disorders. 

This agreement will allow scientists at Lundbeck's global research locations to access Asterand's XpressBANK of human tissue and clinical data and the Phase ZERO drug discovery services platform to advance development of treatments for psychiatric and neurological disorders. Financial terms were not disclosed.


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying